日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

High prevalence of hepatitis C virus infection among incarcerated persons: Results from the Louisiana Hepatitis C Elimination Plan's opt-out testing program in prisons

监狱服刑人员中丙型肝炎病毒感染率高:路易斯安那州丙型肝炎消除计划在监狱中开展的自愿检测项目的结果

Irvin, Risha; Landry, Gia; Jones, Miranda R; James, Anthony; Schexnayder, Jean; Rodriguez, Stacye; Wendell, Deborah; Barthe, Kathryn; Britton, Elizabeth; LeSar, Kendra; Manogue, Sean; Sugarman, Olivia K; Brown, Cynthia; Burgess, Samuel; Mehta, Shruti H; Thomas, David L; Robinson, William

Increasing pre-exposure prophylaxis (PrEP) in primary care: A study protocol for a multi-level intervention using the multiphase optimization strategy (MOST) framework

在基层医疗中加强暴露前预防(PrEP):一项采用多阶段优化策略(MOST)框架的多层次干预研究方案

Lockhart, Elizabeth; Turner, DeAnne; Guastaferro, Kate; Szalacha, Laura A; Alzate, Herica Torres; Marhefka, Stephanie; Pittiglio, Bianca; Dekker, Megan; Yeh, Hsueh-Han; Zelenak, Logan; Toney, Jeremy; Manogue, Sean; Ahmedani, Brian K

Black Patients with Metastatic Castrate-Resistant Prostate Cancer Have a Shorter Time Interval Between PSA and Clinical Progression on Novel Hormonal Therapies plus Avelumab

接受新型激素疗法联合阿维鲁单抗治疗的转移性去势抵抗性前列腺癌黑人患者,其PSA升高与临床进展之间的时间间隔较短。

Hawkins, Charlotte Manogue; Barata, Pedro C; Cotogno, Patrick; Davis, Gaynelle; Jaeger, Ellen; Ledet, Elisa; Miller, Patrick; Lewis, Brian; Sartor, Oliver; Layton, Jodi

Thiocarbazate building blocks enable the construction of azapeptides for rapid development of therapeutic candidates

硫代氨基甲酸酯结构单元可用于构建氮杂肽,从而快速开发治疗候选药物。

Altiti, Ahmad; He, Mingzhu; VanPatten, Sonya; Cheng, Kai Fan; Ahmed, Umair; Chiu, Pui Yan; Mughrabi, Ibrahim T; Jabari, Bayan Al; Burch, Ronald M; Manogue, Kirk R; Tracey, Kevin J; Diamond, Betty; Metz, Christine N; Yang, Huan; Hudson, LaQueta K; Zanos, Stavros; Son, Myoungsun; Sherry, Barbara; Coleman, Thomas R; Al-Abed, Yousef

Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

一项随机II期临床试验,评估Sipuleucel-T联合或不联合镭-223治疗骨转移性去势抵抗性前列腺癌男性患者的疗效

Marshall, Catherine H; Fu, Wei; Wang, Hao; Park, Jong Chul; DeWeese, Theodore L; Tran, Phuoc T; Song, Daniel Y; King, Serina; Afful, Michaella; Hurrelbrink, Julia; Manogue, Charlotte; Cotogno, Patrick; Moldawer, Nancy P; Barata, Pedro C; Drake, Charles G; Posadas, Edwin M; Armstrong, Andrew J; Sartor, Oliver; Antonarakis, Emmanuel S

Changes in taste and smell of food during prostate cancer treatment

前列腺癌治疗期间食物味觉和嗅觉的变化

Alonzi, Sarah; Hoerger, Michael; Perry, Laura M; Chow, Lydia D; Manogue, Charlotte; Cotogno, Patrick; Ernst, Emma M; Ledet, Elisa M; Sartor, Oliver

Long-Term Disease Control Using Taxane/Platinum-Based Chemotherapy in CDK12-Mutated Advanced Prostate Cancer

采用紫杉烷/铂类化疗治疗CDK12突变型晚期前列腺癌的长期疾病控制

Barata, Pedro; Ledet, Elisa; Manogue, Charlotte; Cotogno, Patrick; Harris, Kendra; Lewis, Brian; Layton, Jodi; Sartor, Oliver

Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort

一线PD-1/PD-L1抑制剂单药治疗转移性肾细胞癌(mRCC)的疗效:一项多中心队列研究

Barata, Pedro; Hatton, Whitley; Desai, Arpita; Koshkin, Vadim; Jaeger, Ellen; Manogue, Charlotte; Cotogno, Patrick; Light, Malcolm; Lewis, Brian; Layton, Jodi; Sartor, Oliver; Basu, Arnab; Kilari, Deepak; Emamekhoo, Hamid; Bilen, Mehmet A

Evaluation of the genomic alterations in the androgen receptor gene during treatment with high-dose testosterone for metastatic castrate-resistant prostate cancer

评估高剂量睾酮治疗转移性去势抵抗性前列腺癌期间雄激素受体基因的基因组改变

Moses, Marcus; Koksal, Ulkuhan; Ledet, Elisa; Manogue, Charlotte; Cotogno, Patrick; Lewis, Brian; Layton, Jodi; Sartor, A Oliver; Barata, Pedro

Biomarkers for Programmed Death-1 Inhibition in Prostate Cancer

前列腺癌中程序性死亡受体-1抑制的生物标志物

Manogue, Charlotte; Cotogno, Patrick; Ledet, Elisa; Lewis, Brian; Wyatt, Alexander W; Sartor, Oliver